Sign Out
Hypersensitivity to the active substances or to any of the excipients listed in Description. See Precautions and Adverse Reactions.
Co-administration with medicinal products with narrow therapeutic windows, that are substrates of organic cation transporter (OCT) 2, including but not limited to fampridine (also known as dalfampridine; see Interactions).
